Overview
RNF11 (RING Finger Protein 11) is a small RING-type E3 ubiquitin ligase that functions as a critical regulator of NF-kB signaling and other cellular pathways1RNF11: a modular E3 ligase that regulates NF-kB and cell deathOpen reference. It is expressed in various tissues, including the brain, and plays important roles in immune response and cell survival. As a modular signaling protein, RNF11 contains multiple functional domains that enable it to interact with various signaling complexes and regulate diverse cellular processes2Modulation of NF-kB activity by the RING finger protein RNF11Open reference.
The human RNF11 gene encodes a 154-amino acid protein with a C3HC4 RING finger domain at its C-terminus, flanked by proline-rich regions and potential phosphorylation sites. This structure allows RNF11 to serve as a molecular scaffold, bringing together different signaling components and modulating their activity through ubiquitination3The ubiquitin system and immune-mediated diseaseOpen reference.
Normal Function
RNF11 is a modular signaling protein with multiple functional domains that enable it to participate in various cellular processes:
E3 Ubiquitin Ligase Activity
RNF11 contains a functional RING finger domain that catalyzes ubiquitin transfer to target proteins4Ubiquitination and deubiquitination in neurodegenerative diseasesOpen reference. This enzymatic activity is essential for:
-
Protein degradation: Targeting specific proteins for ubiquitin-proteasome system (UPS) mediated degradation
-
Signaling modulation: Altering the activity of signaling proteins through monoubiquitination or polyubiquitination
-
Quality control: Facilitating the removal of misfolded or damaged proteins
The E3 ligase activity of RNF11 is regulated by multiple factors including phosphorylation state, protein interactions, and cellular context. Studies have shown that RNF11 can both activate and inhibit ubiquitination depending on the specific target and cellular conditions5RING finger protein 11 regulates cell proliferation and invasion in breast cancerOpen reference.
NF-kB Regulation
RNF11 functions as both a positive and negative regulator of NF-kB signaling depending on context6NF-kB in neurodegenerative disease: the therapeutic potential of targeting the pathwayOpen reference. This dual regulatory function is mediated through:
-
Direct interaction with TRAF proteins: RNF11 binds to TRAF2 and TRAF6, key E3 ligases in the NF-kB activation pathway
-
IKK complex modulation: RNF11 can regulate IKK activity, the critical kinase complex that phosphorylates I-kB inhibitors
-
Negative feedback regulation: Under certain conditions, RNF11 promotes the degradation of positive NF-kB regulators
The balance between RNF11’s positive and negative effects on NF-kB signaling is crucial for maintaining proper immune responses. Dysregulation of this balance has been implicated in various pathological conditions including chronic inflammation and neurodegeneration7TRAF6 and RNF11: dual regulators of NF-kB in immune and neurodegenerative signalingOpen reference.
MAPK Signaling
Beyond NF-kB, RNF11 modulates ERK and JNK MAPK pathways2Modulation of NF-kB activity by the RING finger protein RNF11Open reference. These pathways are critical for:
-
Cell proliferation and differentiation
-
Stress responses
-
Apoptosis regulation
-
Synaptic plasticity in neurons
RNF11’s modulation of MAPK signaling involves interactions with MAP3K1 and other upstream kinases, creating a complex network of regulatory interactions that influence cellular outcomes.
Role in Neurodegeneration
Neuroinflammation
RNF11 is a key modulator of neuroinflammatory processes that underlie many neurodegenerative diseases8The role of neuroinflammation in neurodegenerative diseasesOpen reference. The protein’s role in neuroinflammation encompasses multiple aspects:
Microglial Activation
Microglia are the resident immune cells of the central nervous system and play a central role in neurodegeneration9Neuroinflammation in Alzheimer's disease: the role of microglia and astrocytesOpen reference. RNF11 regulates NF-kB-dependent inflammatory cytokine production in microglia, including:
-
TNF-alpha: A pro-inflammatory cytokine that promotes neuronal death
-
IL-1beta: Interleukin-1 beta that contributes to chronic neuroinflammation
-
IL-6: Interleukin-6 that modulates neuroinflammation and synaptic function
Microglial activation in response to pathological stimuli leads to a sustained inflammatory response that exacerbates neurodegeneration. RNF11’s regulation of this process makes it a potential therapeutic target for modulating neuroinflammation2Modulation of NF-kB activity by the RING finger protein RNF11Open reference0.
Cytokine Signaling
RNF11 modulates TNF receptor signaling cascades through direct interactions with TNFR-associated signaling complexes2Modulation of NF-kB activity by the RING finger protein RNF11Open reference1. This modulation affects:
-
Downstream NF-kB and MAPK activation
-
Caspase-8 mediated apoptosis
-
Necroptosis pathways
The deregulation of cytokine signaling contributes to the chronic neuroinflammation observed in Alzheimer’s disease (AD), Parkinson’s disease (PD), and other neurodegenerative conditions.
Alzheimer’s Disease
In Alzheimer’s disease, RNF11 contributes to pathogenesis through multiple mechanisms2Modulation of NF-kB activity by the RING finger protein RNF11Open reference2:
Amyloid Processing
RNF11 influences amyloid precursor protein (APP) trafficking and processing through its effects on cellular trafficking pathways. The ubiquitin-proteasome system plays a crucial role in regulating APP metabolism, and RNF11’s E3 ligase activity can affect:
-
Alpha-secretase processing and non-amyloidogenic APP cleavage
-
Beta-secretase access to APP
-
Amyloid-beta secretion and aggregation
Tau Pathology
Through its interactions with the ubiquitin system, RNF11 may influence tau protein clearance and aggregation2Modulation of NF-kB activity by the RING finger protein RNF11Open reference3. The UPS is critical for removing abnormal tau species, and RNF11 dysregulation could contribute to:
-
Impaired tau clearance
-
NFT formation
-
Spreading of tau pathology
Neuronal Apoptosis
RNF11 modulates TNF-alpha-mediated neuronal apoptosis, a key mechanism of neuronal loss in AD. The protein’s regulation of:
-
NF-kB-dependent survival signals
-
Caspase activation
-
Mitochondrial apoptosis pathways
affects the balance between survival and death in neurons exposed to inflammatory stress.
Parkinson’s Disease
In Parkinson’s disease, RNF11’s role in neuroinflammation and protein clearance is particularly relevant2Modulation of NF-kB activity by the RING finger protein RNF11Open reference4:
Dopaminergic Neuron Survival
NF-kB dysregulation affects viability of dopaminergic neurons in the substantia nigra. RNF11’s modulation of NF-kB signaling influences:
-
Pro-survival gene expression
-
Inflammatory cascade activation
-
Mitochondrial function
Loss of dopaminergic neurons is the hallmark pathological feature of PD, and RNF11-mediated inflammation contributes to this process.
Alpha-Synuclein Toxicity
RNF11 may influence inflammatory pathways triggered by alpha-synuclein aggregation2Modulation of NF-kB activity by the RING finger protein RNF11Open reference5. The protein’s role in:
-
Protein clearance mechanisms
-
Inflammatory signaling activation
-
Glial cell responses
makes it relevant to the pathogenesis of PD and other synucleinopathies.
Glial Activation
RNF11 controls inflammatory responses in astrocytes and microglia, the two major glial cell types involved in neuroinflammation. Activated glia produce:
-
Pro-inflammatory cytokines
-
Reactive oxygen species
-
Nitric oxide
These factors contribute to neuronal damage and disease progression.
Multiple System Atrophy
RNF11 may play a role in Multiple System Atrophy (MSA), a neurodegenerative disorder characterized by:
-
Glial cytoplasmic inclusions
-
Autonomic dysfunction
-
Parkinsonian symptoms
The protein’s functions in protein clearance and neuroinflammation are relevant to the pathogenesis of this disorder.
Molecular Mechanisms
RNF11-mediated neurodegeneration involves multiple interconnected molecular pathways:
NF-kB Hyperactivation
Enhanced NF-kB signaling leads to increased pro-inflammatory cytokine production2Modulation of NF-kB activity by the RING finger protein RNF11Open reference6. The mechanisms include:
-
Constitutive IKK activation: Persistent activation of the IKK complex
-
Reduced I-kB reserves: Degradation of NF-kB inhibitors
-
Nuclear translocation: Enhanced NF-kB nuclear localization and DNA binding
This hyperactivation creates a feed-forward loop where inflammation promotes more inflammation through NF-kB-dependent gene expression.
Ubiquitin-Proteasome System Dysfunction
The UPS is critical for cellular protein homeostasis, and RNF11 plays a role in regulating this system2Modulation of NF-kB activity by the RING finger protein RNF11Open reference7:
-
Altered protein degradation affects cellular homeostasis
-
Accumulation of damaged proteins
-
Impaired clearance of pathological protein aggregates
UPS dysfunction is a common feature of many neurodegenerative diseases and is closely linked to RNF11 function.
Mitochondrial Dysfunction
NF-kB-mediated effects on mitochondrial quality control include:
-
Altered mitophagy
-
Increased mitochondrial permeability
-
Reduced ATP production
-
Enhanced ROS production
Mitochondrial dysfunction is a key contributor to neurodegeneration and is influenced by RNF11’s regulatory functions.
Oxidative Stress
Inflammatory activation increases reactive oxygen species (ROS) production. RNF11 contributes to oxidative stress through:
-
Microglial NADPH oxidase activation
-
Mitochondrial ROS generation
-
Reduced antioxidant capacity
Oxidative stress damages lipids, proteins, and DNA, contributing to neuronal death.
Protein Interactions
RNF11 interacts with multiple proteins to execute its cellular functions:
| Protein | Interaction Type | Functional Outcome |
|---|---|---|
| TRAF2 | Direct binding | NF-kB activation modulation |
| TRAF6 | Direct binding | NF-kB and MAPK signaling |
| TAK1 | Kinase complex | Signal transduction |
| IKK complex | Regulatory interaction | NF-kB activation |
| TAB2/TAK1 | Complex formation | Downstream signaling |
| A20 | Negative regulation | Feedback inhibition |
| UBC13 | Ubiquitin-conjugating enzyme | K63-linked ubiquitination |
Therapeutic Implications
Targeting RNF11 signaling represents a potential therapeutic approach2Modulation of NF-kB activity by the RING finger protein RNF11Open reference8:
NF-kB Inhibitors
Reducing downstream inflammatory signaling through:
-
Direct NF-kB pathway inhibitors
-
IKK inhibitors
-
Proteasome inhibitors that reduce NF-kB activation
Ubiquitin Modulators
Targeting RNF11 E3 ligase activity through:
-
Small molecule E3 ligase modulators
-
PROTAC-based degraders
-
UPS enhancers
Microglial Modulators
Reducing neuroinflammation through microglial pathway targeting:
-
Colony-stimulating factor 1 receptor (CSF1R) antagonists
-
TREM2 agonists
-
Anti-inflammatory compounds
Research Directions
Biomarker Potential
RNF11 expression could serve as a biomarker for:
-
Neuroinflammatory status
-
Disease progression
-
Treatment response
Drug Development
Potential therapeutic strategies include:
-
Gene therapy approaches
-
Small molecule inhibitors
-
Antibody-based therapies
Summary
RNF11 is a multifunctional RING finger protein that plays critical roles in regulating NF-kB signaling, neuroinflammation, and protein degradation in the brain. Its functions in microglial activation, neuronal survival, and protein clearance make it relevant to the pathogenesis of multiple neurodegenerative diseases including Alzheimer’s disease, Parkinson’s disease, and Multiple System Atrophy. Understanding RNF11’s complex regulatory functions provides insights into disease mechanisms and potential therapeutic targets.
See Also
External Links
References
- RNF11: a modular E3 ligase that regulates NF-kB and cell death
- Modulation of NF-kB activity by the RING finger protein RNF11
- The ubiquitin system and immune-mediated disease
- Ubiquitination and deubiquitination in neurodegenerative diseases
- RING finger protein 11 regulates cell proliferation and invasion in breast cancer
- NF-kB in neurodegenerative disease: the therapeutic potential of targeting the pathway
- TRAF6 and RNF11: dual regulators of NF-kB in immune and neurodegenerative signaling
- The role of neuroinflammation in neurodegenerative diseases
- Neuroinflammation in Alzheimer's disease: the role of microglia and astrocytes
- Microglial activation and its implications in the study of animal models of Parkinson's disease
- Microglial NF-kB activation in Parkinson's disease: therapeutic implications
- Ubiquitin-proteasome system in Alzheimer's disease
- E3 ubiquitin ligases in tauopathies and alpha-synucleinopathies
- Ubiquitin-proteasome system dysfunction in Parkinson's disease
- The role of E3 ligases in protein aggregation and neurodegeneration
- RNF11 modulates microglial activation through NF-kB signaling pathway
- Altered ubiquitin-proteasome system in aging and neurodegenerative disease
- Targeting E3 ubiquitin ligases for neurodegenerative disease therapy
Sister wikis (recently updated · no domain on this page)
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- test
- JGBO-I27: Top 10 GBO Questions for Prioritization
- JGBO-I27: Top 10 GBO Questions for Prioritization
- Design Brief: Beta-test Evaluation Protocol for SciDEX v2 Design Trajectories
- Andy — Showcase Findings (auto-curated)
- Kris — Showcase Findings (auto-curated)
Recent activity here
No recent events touching this page.